Lin Zheng

Lin Zheng practices at Inspira Medical Center Vineland in Vineland, New Jersey, part of Inspira Health Network.

Lin Zheng's NPI, 1598095747, was assigned on January 12, 2010. Lin Zheng holds Delaware license C1-0024131.

Lin Zheng's primary practice is Inspira Medical Center Vineland, at 1505 W Sherman Ave, Vineland, NJ 08360 in Cumberland County. The practice phone is (856) 641-8000.

Lin Zheng's primary practice is Inspira Medical Center Vineland in Vineland, New Jersey, part of Inspira Health Network. Lin Zheng is also affiliated with Cooper University Hospital. The medical group on file is CompleteCare Health Network. Dmand AI also links Lin Zheng to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lin Zheng practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Lin Zheng's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Lin Zheng is licensed in Delaware.

CMS data shows 598 Medicare services from Lin Zheng across 5 procedure codes in 2024, for 275 Medicare patients. Medicare paid $48,024 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 275 Medicare patients who saw Lin Zheng in 2024. The largest group is 75 to 84, with 94 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Lin Zheng's median patient age at 64, with 49% women.

In 2024, Lin Zheng wrote 204 Medicare Part D claims for 105 patients. 85% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $27 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Lin Zheng for performance year 2024, reported through an alternative payment model (APM). Lin Zheng accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 12 general payments to Lin Zheng from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $68.